> Intarcia Therapeutics set the terms of their IPO at 5 million shares priced from $12 to $14 each. Story
> SkinMedica set its IPO terms today, with plans to sell 5.25 million shares at $11 to $13 each. Report
> VaxGen is touting a new study in the Journal of Virology which shows that a single dose of its new smallpox vaccine worked to protect mice from a variant of the disease. Release
> Chutes & Ladders: Alexion Pharmaceuticals has appointed Vikas Sinha as senior vice president and CFO. Release
And Finally... A federal grand jury's recent indictment of three businesses in Kansas City for their attempt to sell $42 million in counterfeit drugs illustrates just how fast this illicit business is growing. Story